Resolution of lung adenocarcinoma after discontinuation of ibrutinib

od Khashab, Tamer, Loghavi, Sanam, Konoplev, Sergej N, Samaniego, Felipe
izdano v BMJ Case Rep (2016)

Discovery of imatinib-responsive FIP1L1-PDGFRA mutation during refractory acute myeloid leukemia transformation of chronic myelomonocytic leukemia

od Shah, Shilpan, Loghavi, Sanam, Garcia-Manero, Guillermo, Khoury, Joseph D
Izdano 2014

Pan-RAF Inhibition Shows Anti-Leukemic Activity in RAS-Mutant Acute Myeloid Leukemia Cells and Potentiates the Effect of Sorafenib in Cells with FLT3 Mutation

od Khoury, Joseph D., Tashakori, Mehrnoosh, Yang, Hong, Loghavi, Sanam, Wang, Ying, Wang, Jing, Piya, Sujan, Borthakur, Gautam
izdano v Cancers (Basel) (2020)

Durable remission with rituximab in a patient with an unusual variant of Castleman's disease with myelofibrosis—TAFRO syndrome

od Jain, Preetesh, Verstovsek, Srdan, Loghavi, Sanam, Jorgensen, Jeffrey L., Patel, Keyur P., Estrov, Zeev, Fayad, Luis, Pemmaraju, Naveen
izdano v Am J Hematol (2015)

DNMT3A, TET2 and JAK2 mutations in polycythemia vera (PV) following long- term remission of secondary acute myeloid leukemia (AML)

od Jain, Preetesh, Verstovsek, Srdan, Wang, Wei, Loghavi, Sanam, Torres, Harrys A., Estrov, Zeev, Patel, Keyur P., Pemmaraju, Naveen
izdano v Leuk Lymphoma (2015)

Chemokine-Like Receptor-1 Expression by Central Nervous System-Infiltrating Leukocytes and Involvement in a Model of Autoimmune Demyelinating Disease

od Graham, Kareem L., Zabel, Brian A., Loghavi, Sanam, Zuniga, Luis A., Ho, Peggy P., Sobel, Raymond A., Butcher, Eugene C.
Izdano 2009

The Implementation and Effectiveness of PathElective.com

od Lilley, Cullen M., Arnold, Christina A., Arnold, Michael, Booth, Adam L., Gardner, Jerad M., Jiang, Xiaoyin “Sara”, Loghavi, Sanam, Mirza, Kamran M.
izdano v Acad Pathol (2021)

Immunophenotypic and Diagnostic Characterization of Angioimmunoblastic T-cell Lymphoma by Advanced Flow Cytometric Technology

od Loghavi, Sanam, Wang, Sa A., Medeiros, L. Jeffrey, Jorgensen, Jeffrey L., Li, Xin, Xu-Monette, Zijun Y., Miranda, Roberto N., Young, Ken H.
izdano v Leuk Lymphoma (2016)

Myeloid neoplasms with concurrent BCR-ABL1 and CBFB rearrangements: A series of 10 cases of a clinically aggressive neoplasm

od Salem, Alireza, Loghavi, Sanam, Tang, Guilin, Huh, Yang O., Jabbour, Elias J., Kantarjian, Hagop, Wang, Wei, Hu, Shimin, Luthra, Rajyalakshmi, Medeiros, L. Jeffrey, Khoury, Joseph D.
izdano v Am J Hematol (2017)

Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a ten-color flow cytometric panel for initial workup and residual...

od Wang, Wei, Khoury, Joseph D., Miranda, Roberto N., Jorgensen, Jeffrey L., Xu, Jie, Loghavi, Sanam, Li, Shaoying, Pemmaraju, Naveen, Nguyen, Than, Medeiros, L. Jeffrey, Wang, Sa A.
izdano v Haematologica (2020)

Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients

od Loghavi, Sanam, Alayed, Khaled, Aladily, Tariq N., Zuo, Zhuang, Ng, Siok-Bian, Tang, Guilin, Hu, Shimin, Yin, C. Cameron, Miranda, Roberto N., Medeiros, L. Jeffrey, Khoury, Joseph D.
izdano v J Hematol Oncol (2015)

Bone marrow pathologic abnormalities in familial platelet disorder with propensity for myeloid malignancy and germline RUNX1 mutation

od Kanagal-Shamanna, Rashmi, Loghavi, Sanam, DiNardo, Courtney D., Medeiros, L. Jeffrey, Garcia-Manero, Guillermo, Jabbour, Elias, Routbort, Mark J., Luthra, Rajyalakshmi, Bueso-Ramos, Carlos E., Khoury, Joseph D.
izdano v Haematologica (2017)

Intrauterine Growth Restriction Caused by Underlying Congenital Cytomegalovirus Infection

od Pereira, Lenore, Petitt, Matthew, Fong, Alex, Tsuge, Mitsuru, Tabata, Takako, Fang-Hoover, June, Maidji, Ekaterina, Zydek, Martin, Zhou, Yan, Inoue, Naoki, Loghavi, Sanam, Pepkowitz, Samuel, Kauvar, Lawrence M., Ogunyemi, Dotun
Izdano 2014

Early detection of transformation to BPDCN in a patient with MDS

od Chamoun, Kamal, Loghavi, Sanam, Pemmaraju, Naveen, Konopleva, Marina, Kroll, Michael, Nguyen-Cao, Madeleine, Hornbaker, Marisa, DiNardo, Courtney D., Kadia, Tapan, Jorgensen, Jeffrey, Andreeff, Michael, Hu, Shimin, Benton, Christopher B.
izdano v Exp Hematol Oncol (2018)

RAS and TP53 can predict survival in adults with T‐cell lymphoblastic leukemia treated with hyper‐CVAD

od Sakhdari, Ali, Thakral, Beenu, Loghavi, Sanam, Kanagal‐Shamanna, Rashmi, Yin, C. Cameron, Zuo, Zhuang, Routbort, Mark J., Luthra, Rajyalakshmi, Medeiros, L. Jeffrey, Wang, Sa A., Patel, Keyur P., Ok, Chi Young
izdano v Cancer Med (2019)

NPM1 mutant variant allele frequency correlates with leukemia burden but does not provide prognostic information in NPM1-mutated AML

od Abbas, Hussein A., Ravandi, Farhad, Loghavi, Sanam, Patel, Keyur P., Borthakur, Gautam, Kadia, Tapan M., Jabbour, Elias, Takahashi, Koichi, Cortes, Jorge, Issa, Ghayas C., Konopleva, Marina, Kantarjian, Hagop M., Short, Nicholas J.
izdano v Am J Hematol (2019)

Clinical features of De Novo acute myeloid leukemia with concurrent DNMT3A, FLT3 and NPM1 mutations

od Loghavi, Sanam, Zuo, Zhuang, Ravandi, Farhad, Kantarjian, Hagop M, Bueso-Ramos, Carlos, Zhang, Liping, Singh, Rajesh R, Patel, Keyur P, Medeiros, L Jeffrey, Stingo, Francesco, Routbort, Mark, Cortes, Jorge, Luthra, Rajyalakshmi, Khoury, Joseph D
Izdano 2014

Detection of somatic mutations in cell-free DNA in plasma and correlation with overall survival in patients with solid tumors

od Mehrotra, Meenakshi, Singh, Rajesh R., Loghavi, Sanam, Duose, Dzifa Yawa, Barkoh, Bedia A., Behrens, Carmen, Patel, Keyur P., Routbort, Mark J., Kopetz, Scott, Broaddus, Russell R., Medeiros, L. Jeffrey, Wistuba, Ignacio I., Luthra, Rajyalakshmi
izdano v Oncotarget (2017)

Emergence of BCR–ABL1 Fusion in AML Post–FLT3 Inhibitor-Based Therapy: A Potentially Targetable Mechanism of Resistance – A Case Series

od Alotaibi, Ahmad S., Yilmaz, Musa, Loghavi, Sanam, DiNardo, Courtney, Borthakur, Gautam, Kadia, Tapan M., Thakral, Beenu, Pemmaraju, Naveen, Issa, Ghayas C., Konopleva, Marina, Short, Nicholas J., Patel, Keyur, Tang, Guilin, Ravandi, Farhad, Daver, Naval
izdano v Front Oncol (2020)

Mixed phenotype acute leukemia contains heterogeneous genetic mutations by next-generation sequencing

od Quesada, Andrés E., Hu, Zhihong, Routbort, Mark J., Patel, Keyur P., Luthra, Rajyalakshmi, Loghavi, Sanam, Zuo, Zhuang, Yin, C. Cameron, Kanagal-Shamanna, Rashmi, Wang, Sa A., Jorgensen, Jeffrey L., Medeiros, L. Jeffrey, Ok, Chi Young
izdano v Oncotarget (2018)